CORRECTION article

Front. Cell Dev. Biol., 23 September 2022

Sec. Cancer Cell Biology

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1008088

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

  • LW

    Lin Wang 1

  • XJ

    Xiang-Bo Ji 2

  • LW

    Li-Hong Wang 2

  • JQ

    Jian-Ge Qiu 1

  • FZ

    Feng-Mei Zhou 1

  • WL

    Wen-Jing Liu 3

  • DW

    Di-di Wan 2

  • MC

    Marie Chai-mi Lin 1

  • LL

    Ling-Zhi Liu 4

  • JZ

    Jian-Ying Zhang 2*

  • BJ

    Bing-Hua Jiang 1,4*

  • 1. The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China

  • 2. BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China

  • 3. Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, China

  • 4. Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, United States

In the published article, there was a mistake in the Author Contributions. The author L-ZL was accidentally included in the contribution, “performed qRT-PCR assay, reporter assay and immunoblotting analysis, analyzed chemosensitivity array and animal analysis”, and for authors LW, L-ZL, J-YZ, and B-HJ the contribution “designed the project and revised the manuscript” was accidentally omitted.

The correct Author Contributions appear below:

“LW, X-BJ, and L-HW performed experiments, analyzed data, and wrote the manuscript. J-GQ, W-JL, DW, F-MZ, and ML performed qRT-PCR assay, reporter assay and immunoblotting analysis, analyzed chemosensitivity array and animal analysis. LW, L-ZL, J-YZ, and B-HJ designed the project and revised the manuscript. All authors approved the submitted version.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

MiR-497, Akt2, tumor growth, chemoresistance, NSCLC

Citation

Wang L, Ji X-B, Wang L-H, Qiu J-G, Zhou F-M, Liu W-J, Wan D, Lin MC, Liu L-Z, Zhang J-Y and Jiang B-H (2022) Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer. Front. Cell Dev. Biol. 10:1008088. doi: 10.3389/fcell.2022.1008088

Received

31 July 2022

Accepted

05 August 2022

Published

23 September 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2022

Updates

Copyright

*Correspondence: Bing-Hua Jiang, ; Jian-Ying Zhang,

This article was submitted to Cancer Cell Biology, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics